Xenon Pharmaceuticals Inc. - Special Call

Core Viewpoint - The investor webinar focuses on Xenon Pharmaceuticals' Kv7 and Nav1.7 programs aimed at pain treatment, highlighting the company's leadership in ion channel drug development [1][4]. Company Overview - Ian Mortimer serves as the President and CEO of Xenon Pharmaceuticals and is moderating the session [1]. - The company has a strong pipeline and a history of positioning itself as a leader in ion channel drug development [4]. Key Personnel - Dr. Jim Empfield, Executive Vice President of Drug Discovery, will discuss Xenon's history and its advancements in drug development [3][4]. - Dr. JP Gilbert, Senior Director of Biology, and Dr. Chris Kenney, Chief Medical Officer, are also part of the speaking team [3].